A critical advance in cancer research is occurring with the use of mini-antibodies to reactivate dysfunctional p53. This essential tumor protector protein is frequently inactivated in various kinds of tumors, causing https://bookmark-dofollow.com/story29827648/vhh-fragments-revive-p53-a-potential-hope-for-cancer-treatment